Accounts Receivable, after Allowance for Credit Loss, Current in USD of Cannabis Bioscience International Holdings, Inc. from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Cannabis Bioscience International Holdings, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q2 2011 to Q3 2025.
  • Cannabis Bioscience International Holdings, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending August 31, 2025 was $8.97K, a 47.8% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Cannabis Bioscience International Holdings, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $8.97K -$8.21K -47.8% Aug 31, 2025 10-Q 2025-10-22
Q2 2025 $6.38K -$13.8K -68.3% May 31, 2025 10-Q 2025-10-22
Q1 2025 $2.64K -$14.4K -84.5% Feb 28, 2025 10-Q/A 2025-05-09
Q3 2024 $17.2K Aug 31, 2024 10-Q 2024-10-21
Q2 2024 $20.1K +$10.2K +102% May 31, 2024 10-K 2025-09-22
Q1 2024 $17K Feb 29, 2024 10-Q 2024-04-22
Q4 2023 $19.4K Nov 30, 2023 10-Q 2024-01-25
Q2 2023 $9.95K May 31, 2023 10-K 2024-09-16
Q1 2012 $22.8M* Feb 29, 2012 10-Q 2012-04-20
Q4 2011 $47.5M* Nov 30, 2011 10-Q 2012-01-23
Q3 2011 $43.5M* Aug 31, 2011 10-Q/A 2011-11-07
Q2 2011 $30.1M* May 31, 2011 10-Q 2012-04-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.